Not all substrates of GALNT6 have been defined, a recent report indicates that GRP78 is one of the substrates in breast cancer cells24, but it is unclear whether GALNT6 can O-glycosylate GRP78 to regulate the EMT process in lung adenocarcinoma cells. The gene discussed is GALNT6; the disease is breast cancer.